Contact Twinn


  • By Lanner
  • In News
  • Posted 04/07/2013

Human Genome Company Selects WITNESS Predictive Simulation Technology

Lanner is delighted to announce that Complete Genomics, developers of a proprietary whole human genome sequencing technology, has invested in its WITNESS predictive simulation platform at Complete Genomics’ Mountain View headquarters, California.

The agreement means WITNESS will become instrumental in simulating and optimizing business processes at Complete Genomics as the company focuses on providing biological researchers with highly accurate, interpretable human genome data ready for interpretation.

Having selected WITNESS based on its ability to rapidly model the complex, interconnected processes used to deliver accurate DNA sequencing, Matt Morenzoni, Biomolecular Systems Scientist, Complete Genomics comments, 

“In an industry driven by innovation, precision and speed it is imperative that the best business outcomes are found most effectively.” 

Mandy Tague, Lanner Director of Business Development, says:

“By choosing predictive simulation to gain insight into the operations of their business, Complete Genomics will be able to make confident decisions that will allow them to meet the increasing demand for their services.”
She continues, “Experimenting with the firm's end-to-end service methods that include process automation, sample preparation, computing infrastructure, and service delivery technology allows Complete Genomics to maximize throughput. This provides the firm's research clients with highly accurate genomic data, assembled and annotated, ready for biological interpretation with optimum efficiency.” 

Loading blog comments..

Post a Comment

Thank you, your comment is awating approval